Pfizer's Dividend Dream: Wait for Growth
from The Daily News Now! Business
Pfizers stock, currently undervalued due to falling COVID vaccine sales and patent cliffs, presents a lucrative opportunity for dividend-focused investors. Despite challenges, Pfizer is actively expanding its portfolio with promising drugs and strategic partnerships. Offering a high dividend yield, its a solid income play with potential for significant growth if their innovations succeed. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/b69a21e75f2b2364
Embed this episode
No transcript yet.